
Embecta Investors Face 57% Stock Drop Amid Class Action Lawsuit
A 57% plunge in Embecta Corp. shares on May 5, 2026, has triggered a class action lawsuit, with Robbins LLP seeking investors who suffered losses during a period of allegedly misleading financial guidance. The medical device manufacturer saw its stock plummet to $3.90 after missing revenue targets and slashing its dividend.


























